Posted in | News | Copper | Mining Business

Arizona Sonoran Closes C$2.5 Million Private Placement with Nuton LLC, a Rio Tinto Venture

Arizona Sonoran Copper Company Inc. (“ASCU” or the “Company”) an emerging US-based copper developer and near-term producer, is pleased to announce that further to its press release dated Feb 16, 2023, it has closed a non-brokered private placement financing in respect of the exercise by Nuton LLC (“Nuton”) of its pre-emptive rights under its Investor Rights Agreement (as defined herein) (the “Private Placement”).

Pursuant to the terms of the investor rights agreement dated May 13, 2022 and as assigned to Nuton on February 9, 2023 (the “Investor Rights Agreement”), Nuton elected to exercise its pre-emptive rights in respect of the Company’s C$30,000,000 bought deal public offering (see PR dated Feb 16, 2023) to maintain its 7.2% ownership interest in the Company. Accordingly, Nuton subscribed for 1,229,140 common shares of the Company (the “Common Shares”) at a price of C$2.00 per Common share for aggregate gross proceeds to the Company of C$2,458,280.

The Common Shares issued under the Private Placement are subject to a statutory hold period under applicable Canadian securities laws expiring on August 1, 2023. The Private Placement is subject to the final approval of the Toronto Stock Exchange.

Nuton offers a portfolio of proprietary copper leach related technologies and capability developed by Rio Tinto to deliver increased copper recovery from primary sulphide material and leading environmental performance. Nuton is currently column leach testing samples of mineralized material from the Cactus and Parks/Salyer Projects, including the primary sulphides.

Neither the Toronto Stock Exchange nor the regulating authority has approved or disproved the information contained in this press release.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.